Mindfulness-Based Relapse Prevention for Substance Use Disorders : a Systematic Review / Sean Grant, Susanne Hempel, Benjamin Colaiaco, Aneesa Motala, Roberta M. Shanman, Marika Booth, Whitney Dudley, Melony E. Sorbero.
Includes bibliographical references (pages 53-58).
Contents
Preface -- Abstract -- Figures -- Tables -- Summary -- Acknowledgments -- Abbreviations -- Chapter One: Introduction: Description of the Condition -- Description of the Intervention -- How the Intervention Might Work .-- Why It Is Important to Do This Review -- Objective -- Chapter Two: Methods: Key Questions -- Search Strategy -- Eligibility Criteria -- Inclusion Screening -- Data Extraction -- Risk of Bias -- Data Synthesis -- Quality of Evidence -- Chapter Three: Results: Results of the Search .-- Description of Included Studies -- Study Quality and Risk of Bias for Individual Included Studies.-- KQ 1: What Is the Efficacy and Safety of MBRP, as an Adjunctive or Monotherapy, for Any Substance Use Versus Any Comparator? -- Relapse -- Frequency of Substance Use -- Withdrawal/Craving Symptoms -- Treatment Dropout -- Health-Related Quality of Life -- Functional Status -- Recovery Outcomes -- Adverse Events -- KQ 1a: Does the Effect of MBRP Vary by the Substance Targeted (i.e., Alcohol, Opioids, Stimulants, or Cannabis)? -- Alcohol Use -- Stimulant Use -- KQ 1b: Does the Effect of MBRP Differ If MBRP Is Offered as an Adjunctive Therapy Rather Than as a Monotherapy? -- Mindfulness-Based Relapse Prevention as a Monotherapy -- Mindfulness-Based Relapse Prevention as an Adjunctive Therapy.-- KQ 1c: Does the Effect of MBRP on SUDs Depend on the Comparator? -- Mindfulness-Based Relapse Prevention Versus Treatment as Usual -- Mindfulness-Based Relapse Prevention Versus Active Comparator -- Chapter Four: Discussion: Summary of Findings -- Other Reviews in This Area -- Strengths and Limitations -- Implications for Future Research and Practice -- Appendix A: Search Strategy -- Appendix B: Excluded Full-Text Articles -- References.
Summary
"RAND researchers conducted a systematic review that synthesized evidence from randomized controlled trials of Mindfulness-Based Relapse Prevention (MBRP)--used as an adjunctive therapy or monotherapy--to provide estimates of its efficacy and safety for treating adults diagnosed with alcohol, opioid, stimulant, or cannabis use disorder"--Publisher's description
Note
Online resource; title from PDF title page (RAND, viewed August 19, 2015).
